The European Society of Cardiology (ESC) Annual Meeting 2005.
von Haehling
Stephan
S
Imperial College School of Medicine, National Heart and Lung Institute, London, UK.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002309:Cardiology; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D005060:Europe; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D012955:Societies, Medical; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D010726:Phosphodiesterase Inhibitors